

An independent corporate and investor communications consultancy serving public and private life science, biotech and biopharma companies.
I help life science, biotech, and biopharma companies define their narrative, build credibility, and navigate pivotal stages of growth.
EHC is the right partner when your company is at a critical inflection point—whether emerging from stealth, preparing for an IPO, securing funding, or managing high-stakes communications.
For early-stage companies that aren’t yet ready for a full-time head of communications or investor relations, I'm a thought partner that scales with your needs. I also work alongside in-house teams that require experienced leadership for critical milestones, expanded coverage, or complex challenges.
With a fractional model, I offer hands-on strategic guidance without the overhead of a full-time hire. When additional expertise is needed—from capital markets advisory to technical web development, or other specialized areas—I bring in vetted senior consultants to ensure seamless execution.
My approach is strategic, outcome-driven, and scalable—aligning communications with business objectives to help companies raise capital, secure partnerships, attract talent, and build market credibility.
Learn more about my background on LinkedIn.
Let's connect.